Responses
Treatments
Original article
Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn’s disease: a pooled analysis of 11 317 patients across clinical trials
Compose a Response to This Article
Other responses
No responses have been published for this article.